When taking GLP-1 medications, your appetite is significantly reduced, making it harder to get enough protein from regular meals
JAMA Netw Open 7(10):e2439887e2439887 Wang L, Wang W, Kaelber DC, Xu R, Berger NA (2024) GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity
The FTC's Health Products Compliance Guidance requires that weight-loss claims be backed by "competent and reliable scientific evidence," which generally means at least one well-designed human trial on the specific finished product
However, it is currently unclear and to what extent the differences observed in CVOT reflect the heterogeneous pharmacological properties of each drug in the GLP-1RA category
For patients managing the complex, overlapping symptoms of Long COVID, ME/CFS, and dysautonomia, targeted supplementation with methylcobalamin may help alleviate several debilitating issues